William Harris Investors’s Teva Pharmaceuticals TEVA Stock Holding History

William Harris Investors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5.43M	Buy	+149,704	New	+$5.98M	1.56%	29

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

William Harris Investors's TEVA Position: Q4 2016 in Review

William Harris Investors opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2016: 149,704 shares worth $5.43M. The stake represents 1.56% of the portfolio and ranks #29 among its holdings.

737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

William Harris Investors held 149,704 shares of Teva Pharmaceuticals worth $5.43M as of Q4 2016.
Teva Pharmaceuticals was a new William Harris Investors position in Q4 2016.
Teva Pharmaceuticals made up 1.56% of William Harris Investors's portfolio in Q4 2016, its #29 holding.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on William Harris Investors's 13F filing for Q4 2016, filed 7 Feb 2017.